Published in Healthcare Finance, Tax and Law Weekly, July 12th, 2006
The board changes will become effective at the closing of the securities purchase agreement previously entered into by Aksys and Durus Life Sciences Master Fund, Ltd., which is anticipated to occur on or about June 23, 2006.
As previously announced, at the closing of the securities purchase agreement, Durus will exchange approximately $5.0 million of existing subordinated promissory notes of the company currently held by Durus for new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.